Valentin Bruttel is CSO and co-founder of Toleris Biotherapeutics GmbH. He holds a Bachelor of Science in Biomedicine, a Master of Science in Molecular Medicine and completed a PhD in tumor immunology. He co-invented a platform for precision immunosuppressants, published numerous peer reviewed papers, is inventor of 9 granted and pending patents and received several awards and fellowships.